These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2827044)

  • 41. Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension.
    Todd PA; Goa KL
    Drugs; 1992 Mar; 43(3):346-81. PubMed ID: 1374319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.
    Applegate W; Cohen JD; Wolfson P; Davis A; Green S
    Pharmacotherapy; 1997; 17(1):107-12. PubMed ID: 9017770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Individual responses to converting enzyme inhibitors and calcium antagonists.
    Bidiville J; Nussberger J; Waeber G; Porchet M; Waeber B; Brunner HR
    Hypertension; 1988 Feb; 11(2):166-73. PubMed ID: 2830189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A multicentre study to compare the therapeutic efficacy of sustained-release diltiazem and enalapril in the treatment of patients with mild to moderate hypertension.
    Weir RJ; Lee PS; Clegg DS; Hemingray S; Belgrave GP; Walter E
    Br J Clin Pract; 1994; 48(6):287-92. PubMed ID: 7848788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of the efficacy and tolerability of enalapril and sustained-release diltiazem in mild to moderate essential hypertension.
    Weir MR; Haynie R; Vertes V; Pinson R; Kong BW; Jenkins P; Lavin PT
    Clin Ther; 1990; 12(6):473-81. PubMed ID: 2289216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiotensin-converting enzyme inhibitor versus calcium antagonist in the treatment of hypertension.
    Brunner HR; Bidiville J; Waeber G; Porchet M; Nussberger J; Waeber B
    Nephron; 1987; 47 Suppl 1():87-9. PubMed ID: 2827044
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experimental and clinical experience with the calcium antagonist diltiazem in hypertension.
    Kiowski W; Linder L; Bühler FR
    J Cardiovasc Pharmacol; 1989; 13 Suppl 1():S25-8. PubMed ID: 2468973
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.